Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$49.24
-0.3%
$57.11
$39.35
$63.33
$100.18B0.4112.97 million shs14.24 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$6.83
-1.1%
$9.30
$6.61
$15.21
$1.20B1.736.24 million shs3.83 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$456.10
-22.0%
$514.51
$438.50
$630.73
$417.20B0.614.39 million shs29.05 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
-0.19%-2.41%-17.86%-12.63%+2.94%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-1.37%-5.48%-18.71%-24.96%-48.04%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
-22.07%-23.35%-9.43%-10.57%-4.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
4.7326 of 5 stars
3.25.04.24.03.43.30.0
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
3.7525 of 5 stars
4.24.00.00.02.62.51.3
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4.7269 of 5 stars
3.63.04.24.03.21.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.32
Hold$57.6717.13% Upside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.39
Hold$10.9460.31% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
3.13
Buy$632.8538.75% Upside

Current Analyst Ratings Breakdown

Latest TDOC, BMY, and UNH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/16/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/11/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$60.00 ➝ $54.00
4/11/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$9.50 ➝ $8.00
4/11/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$610.00 ➝ $660.00
4/9/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$600.00 ➝ $650.00
4/8/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$67.00 ➝ $55.00
3/3/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$16.00 ➝ $13.00
2/27/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$13.00 ➝ $12.00
2/27/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
2/18/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$14.00 ➝ $16.00
2/12/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$11.50 ➝ $13.50
(Data available from 4/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$48.30B2.07$5.19 per share9.48$8.08 per share6.09
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.57B0.47$0.44 per share15.64$14.05 per share0.49
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$400.28B1.04$29.39 per share15.52$106.78 per share4.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
-$8.95B-$4.42N/A8.082.07-18.53%13.93%2.46%4/24/2025 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$220.37M-$5.88N/AN/AN/A-37.91%-10.06%-4.86%4/30/2025 (Estimated)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$14.41B$15.5029.4313.731.373.60%26.69%8.80%N/A

Latest TDOC, BMY, and UNH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2025Q1 2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.32N/AN/AN/A$619.38 millionN/A
4/24/2025Q1 2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$1.55N/AN/AN/A$10.77 billionN/A
4/17/2025Q1 2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$7.29$7.20-$0.09$6.85$111.56 billion$109.58 billion
2/26/2025Q4 2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.21-$0.28-$0.07-$0.28$639.44 million$640.49 million
2/6/2025Q4 2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$1.47$1.67+$0.20$0.04$11.57 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$2.485.04%+6.38%N/A 17 Years
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$8.401.84%+13.46%54.19%15 Years

Latest TDOC, BMY, and UNH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/3/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
quarterly$0.624.14%4/4/20254/4/20255/1/2025
2/24/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$2.101.8%3/10/20253/10/20253/18/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.90
1.25
1.15
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.66
1.73
1.69
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.74
0.83
0.91

Institutional Ownership

CompanyInstitutional Ownership
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
76.41%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
87.86%

Insider Ownership

CompanyInsider Ownership
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
0.07%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.95%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
34,3002.03 billion2.03 billionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,100175.28 million170.53 millionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
400,000914.71 million917.25 millionOptionable

Recent News About These Companies

Analysts set UnitedHealth stock price target
UnitedHealth Group Reports Strong Q1 2025 Results
Q1 2025 UnitedHealth Group Inc Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bristol-Myers Squibb stock logo

Bristol-Myers Squibb NYSE:BMY

$49.24 -0.13 (-0.25%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$49.38 +0.14 (+0.28%)
As of 04/17/2025 06:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Teladoc Health stock logo

Teladoc Health NYSE:TDOC

$6.82 -0.08 (-1.09%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$6.85 +0.03 (+0.42%)
As of 04/17/2025 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

UnitedHealth Group stock logo

UnitedHealth Group NYSE:UNH

$456.10 -128.94 (-22.04%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$454.20 -1.90 (-0.42%)
As of 04/17/2025 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.